ASH 2023
Advertisement
Researchers sought to describe the clinical and sociodemographic characteristics of AYA patients with CLL.
Patients who received CLL/SLL-directed therapies had a lower risk of Richter transformation.
The prevalence of BTK C481 mutations might be higher in CLL patients with longer BTKi exposure.
Venetoclax induces a distinct and prominent transcriptional response in patients with chronic lymphocytic leukemia.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.